Stockreport

Candel Therapeutics to Host Virtual R&D Event on December 5, 2025

Candel Therapeutics, Inc.  (CADL) 
PDF NEEDHAM, Mass., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused [Read more]